Repare Therapeutics Inc (RPTX)

3.25 -0.01 (-0.31%) USD  |  NASDAQ  |  Nov 14, 16:00
3.24 -0.01 (-0.31%) After-Hours: 20:00
More

Repare Therapeutics EPS Diluted (Quarterly): -0.81 for Sept. 30, 2024

EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2019. Upgrade now.
Date Value
September 30, 2024 -0.81
June 30, 2024 -0.82
March 31, 2024 0.30
December 31, 2023 -0.67
September 30, 2023 -0.45
June 30, 2023 -0.28
March 31, 2023 -0.83
December 31, 2022 -0.75
September 30, 2022 1.71
June 30, 2022 -0.91
March 31, 2022 -0.83
December 31, 2021 -0.70
Date Value
September 30, 2021 -0.83
June 30, 2021 -0.71
March 31, 2021 -0.58
December 31, 2020 -0.41
September 30, 2020 -0.37
June 30, 2020 -2.45
March 31, 2020 -0.40
December 31, 2019 -0.3592
September 30, 2019 -0.3315
June 30, 2019 -0.2742
March 31, 2019 -0.2086

Earnings per Share Definition

Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.

Read full definition.

EPS Diluted (Quarterly) Range, Past 5 Years

-2.45
Minimum
Jun 2020
1.71
Maximum
Sep 2022
-0.5575
Average
-0.685
Median

EPS Diluted (Quarterly) Benchmarks

Aurinia Pharmaceuticals Inc 0.10
Edesa Biotech Inc -0.52
Lexaria Bioscience Corp -0.13
InMed Pharmaceuticals Inc -3.80
Xenon Pharmaceuticals Inc -0.75

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -34.41M
Total Expenses (Quarterly) 34.84M
Enterprise Value -40.00M
Earnings Yield -61.73%
Normalized Earnings Yield -50.61